Want to know where doctors go when they aren’t helping patients or meeting with sales reps? It turns out that 60 percent of physicians are using-or are interested in using-online social networks, according to a study released on Tuesday by Manhattan Research.
This is the first year Manhattan Research has looked at the broad impact of social networking on physician behavior. According to Erika S. Fishman, director of research and client services, this year’s inclusion was due to the rise of two big online communities designed for physicians-Medscape Physician Connect and Sermo.
Although most of the data from the survey isn’t unexpected (users tend to be younger, female, primary care doctors, or smart phone owners), item of interest is that physicians that troll online forums prescribe an average of 24 more scrips each week than their unwired peers.
According to Fishman, this prescribing trend could be due to the almost “viral” nature of chat forums and bulletin boards. If one doctor talks about a positive reaction his or her patient had with a treatment option, other physicians could be more apt to prescribe it.
Pharma Outreach
Both physician-oriented social networks offer client-facing products that allow pharma companies to poll physicians and start discussions. All sponsored queries are labeled as such so that doctors can choose to participate in pharma discussions.
On Medscape, drug firms can even purchase sponsorships that allow them to target particular information based on physician practice type and age. According to the study, most physicians have no problem with the sponsors being on the sites, and have even come to expect it, Fishman said.
So does that mean that physicians would be willing to peruse pharma-branded social networks? Don’t count it.
“What makes Sermo and Physician Connect so successful is the idea that it is a private community where physicians are talking together without the obvious knowledge that pharma is there,” Fishman said. “Physicians aren’t going to be attracted to branded sites. Those would have a much lower success rate.”
Off Label and Online
The next question-which currently has no answer-is whether or not pharma companies can disseminate published journal articles to doctors about off-label drug uses through sites such as Sermo. Recently approved FDA regulation gives pharma the authority to distribute articles directly to physicians without federal authorization, and social network sites would be the easiest way to get the word out to many physicians at one time without relying on sales rep foot soldiers.
At press time, Sermo could not be reached to comment on whether any pharma companies had approached them to try such a marketing tactic.
Social Network Use Spikes Among Docs
Pharmaceutical Executive
A new study suggests the medical professionals are more active on social networking sites than ever before. With the rise of doctor-specific Web 2.0 outlets, pharma has a new tool for reaching elusive physicians. The best part: Doctors don?t seem to mind.
Want to know where doctors go when they aren’t helping patients or meeting with sales reps? It turns out that 60 percent of physicians are using-or are interested in using-online social networks, according to a study released on Tuesday by Manhattan Research.
This is the first year Manhattan Research has looked at the broad impact of social networking on physician behavior. According to Erika S. Fishman, director of research and client services, this year’s inclusion was due to the rise of two big online communities designed for physicians-Medscape Physician Connect and Sermo.
Although most of the data from the survey isn’t unexpected (users tend to be younger, female, primary care doctors, or smart phone owners), item of interest is that physicians that troll online forums prescribe an average of 24 more scrips each week than their unwired peers.
According to Fishman, this prescribing trend could be due to the almost “viral” nature of chat forums and bulletin boards. If one doctor talks about a positive reaction his or her patient had with a treatment option, other physicians could be more apt to prescribe it.
Pharma Outreach
Both physician-oriented social networks offer client-facing products that allow pharma companies to poll physicians and start discussions. All sponsored queries are labeled as such so that doctors can choose to participate in pharma discussions.
On Medscape, drug firms can even purchase sponsorships that allow them to target particular information based on physician practice type and age. According to the study, most physicians have no problem with the sponsors being on the sites, and have even come to expect it, Fishman said.
So does that mean that physicians would be willing to peruse pharma-branded social networks? Don’t count it.
“What makes Sermo and Physician Connect so successful is the idea that it is a private community where physicians are talking together without the obvious knowledge that pharma is there,” Fishman said. “Physicians aren’t going to be attracted to branded sites. Those would have a much lower success rate.”
Off Label and Online
The next question-which currently has no answer-is whether or not pharma companies can disseminate published journal articles to doctors about off-label drug uses through sites such as Sermo. Recently approved FDA regulation gives pharma the authority to distribute articles directly to physicians without federal authorization, and social network sites would be the easiest way to get the word out to many physicians at one time without relying on sales rep foot soldiers.
At press time, Sermo could not be reached to comment on whether any pharma companies had approached them to try such a marketing tactic.
Hey Pharma–Do You Know What Your Customers Really Want?
April 24th 2024Gen-Z Influence on Pharma M&A
March 14th 2024Ian Baer, Founder and Chief Soothsayer, Sooth, discusses how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract Gen-Z.
Trends in Continuing Medical Education
April 12th 2024Elliott Yoo, Senior Media Strategist at epocrates, takes a closer look at the trends in CME consumption and what the future of medical education will be – from the priorities for physicians as they juggle learning with patient care, to what type of activities resonate most with prescribers.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
Operating Models for Successful DOL Engagement
March 26th 2024How life sciences companies can design an effective operating model for DOL engagements.
Influencer Marketing, Digital Opinion Leaders
March 25th 2024How consumer goods marketing approaches can support pharmaceutical and life sciences companies in their growth this year.
Hey Pharma–Do You Know What Your Customers Really Want?
April 24th 2024Gen-Z Influence on Pharma M&A
March 14th 2024Ian Baer, Founder and Chief Soothsayer, Sooth, discusses how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract Gen-Z.
Trends in Continuing Medical Education
April 12th 2024Elliott Yoo, Senior Media Strategist at epocrates, takes a closer look at the trends in CME consumption and what the future of medical education will be – from the priorities for physicians as they juggle learning with patient care, to what type of activities resonate most with prescribers.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
Operating Models for Successful DOL Engagement
March 26th 2024How life sciences companies can design an effective operating model for DOL engagements.
Influencer Marketing, Digital Opinion Leaders
March 25th 2024How consumer goods marketing approaches can support pharmaceutical and life sciences companies in their growth this year.